SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ozdemir Ozdemir, Ozgul Altintas, Levent Altintas, Demir Kursat Yildiz, Ender Sener, Yusuf Caglar, Effects of subconjunctivally injected bevacizumab, etanercept, and the combination of both drugs on experimental corneal neovascularization, Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie, 2013, 48, 2, 115

    CrossRef

  2. 2
    Selim Doganay, Penpe Gul Firat, Cem Cankaya, Hale Kirimlioglu, Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn, Burns, 2013, 39, 2, 326

    CrossRef

  3. 3
    Y. Benayoun, R. Rosenberg, G. Casse, B. Dallaudière, P.-Y. Robert, Imagerie et quantification de la néovascularisation cornéenne, Journal Français d'Ophtalmologie, 2013, 36, 8, 693

    CrossRef

  4. 4
    Byung-Yi Ko, Young-sung Kim, Sung-gook Baek, Gun-woong Lee, Jae-Min Kim, Woo-Sean Jean, Nam-Seob Lee, Jaeku Kang, Inhibition of Corneal Neovascularization by Subconjunctival and Topical Bevacizumab and Sunitinib in a Rabbit Model, Cornea, 2013, 32, 5, 689

    CrossRef

  5. 5
    L. Pinsard, F. Malet, J. Colin, D. Touboul, Invasion néovasculaire de l’interface endothélio-descemetique au décours d’une kératoplastie lamellaire antérieure profonde, Journal Français d'Ophtalmologie, 2013, 36, 5, e77

    CrossRef

  6. 6
    Jens Sperling, David Brandhorst, Thilo Schäfer, Christian Ziemann, Anna Benz-Weißer, Claudia Scheuer, Otto Kollmar, Martin K. Schilling, Michael D. Menger, Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy, Clinical & Experimental Metastasis, 2013, 30, 4, 447

    CrossRef

  7. 7
    Sezin Akca Bayar, Cem Kucukerdonmez, Ozlem Oner, Yonca A. Akova, Subconjunctival bevacizumab in the impending recurrent pterygia, International Ophthalmology, 2013,

    CrossRef

  8. 8
    Banu Torun Acar, Elvin Halili, Suphi Acar, The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization, International Ophthalmology, 2013, 33, 5, 507

    CrossRef

  9. 9
    Miltiadis Papathanassiou, Sofia Theodoropoulou, Antonis Analitis, Anastasia Tzonou, Panagiotis G. Theodossiadis, Vascular Endothelial Growth Factor Inhibitors for Treatment of Corneal Neovascularization, Cornea, 2013, 32, 4, 435

    CrossRef

  10. 10
    Hamid Hosseini, Mohammad H Nowroozzadeh, Ramin Salouti, Mahmood Nejabat, Anti-VEGF Therapy With Bevacizumab for Anterior Segment Eye Disease, Cornea, 2012, 31, 3, 322

    CrossRef

  11. 11
    Jin-Hong Chang, Nitin K. Garg, Elisa Lunde, Kyu-Yeon Han, Sandeep Jain, Dimitri T. Azar, Corneal Neovascularization: An Anti-VEGF Therapy Review, Survey of Ophthalmology, 2012, 57, 5, 415

    CrossRef

  12. 12
    Yohan Benayoun, Jean-Paul Adenis, Guillaume Casse, Raimondo Forte, Pierre-Yves Robert, Effects of Subconjunctival Bevacizumab on Corneal Neovascularization, Cornea, 2012, 31, 8, 937

    CrossRef

  13. 13
    Jens Sperling, Thilo Schäfer, Christian Ziemann, Anna Benz-Weißer, Otto Kollmar, Martin K. Schilling, Michael D. Menger, Hepatic arterial infusion of bevacizumab in combination with oxaliplatin reduces tumor growth in a rat model of colorectal liver metastases, Clinical & Experimental Metastasis, 2012, 29, 2, 91

    CrossRef

  14. 14
    Mohammad Naser Hashemian, Hadi Zare Mehrjardi, Sasan Moghimi, Maryam Tahvildary, Hoda Mojazi-Amiri, Prevention of Corneal Neovascularization: Comparison of Different Doses of Subconjunctival Bevacizumab with Its Topical Form in Experimental Rats, Ophthalmic Research, 2011, 46, 1, 50

    CrossRef

  15. 15
    Hsiao-Sang Chu, Fung-Rong Hu, Chung-May Yang, Po-Ting Yeh, Yan-Ming Chen, Yu-Chih Hou, Wei-Li Chen, Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated With Lipid Deposition, Cornea, 2011, 30, 1, 60

    CrossRef

  16. 16
    Deepak Gupta, Chris Illingworth, Treatments for Corneal Neovascularization: A Review, Cornea, 2011, 30, 8, 927

    CrossRef

  17. 17
    H.G. Struck, N.F. Schrage, Verätzungen und Verbrennungen des Auges, Der Ophthalmologe, 2011, 108, 10, 921

    CrossRef

  18. 18
    Charles NJ McGhee, Clinical and Experimental Ophthalmology: a decade of successful evolution, Clinical & Experimental Ophthalmology, 2010, 38, 6
  19. 19
    Richard J Symes, Thomas R G Poole, Corneal Graft Surgery Combined with Subconjunctival Bevacizumab (Avastin), Cornea, 2010, 1

    CrossRef

  20. 20
    Anat Galor, Sonia H. Yoo, Corneal Melt While Using Topical Bevacizumab Eye Drops, Ophthalmic Surgery, Lasers, and Imaging, 2010,

    CrossRef

  21. 21
    Mohammad Reza Fallah, Keivan Khosravi, Mohammad Nasser Hashemian, Amir Hoshang Beheshtnezhad, Mohammad Taher Rajabi, Mohsen Gohari, Efficacy of Topical Bevacizumab for Inhibiting Growth of Impending Recurrent Pterygium, Current Eye Research, 2010, 35, 1, 17

    CrossRef

  22. You have free access to this content22
    Louis Hoffart, Frederic Matonti, John Conrath, Laurent Daniel, Bernard Ridings, Guillaume S Masson, Frederic Chavane, Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone, Clinical & Experimental Ophthalmology, 2010, 38, 4
  23. 23
    Juan J. Pérez-Santonja, Ezequiel Campos-Mollo, Mariola Lledó-Riquelme, Jaime Javaloy, Jorge L. Alió, Inhibition of Corneal Neovascularization by Topical Bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an Animal Model, American Journal of Ophthalmology, 2010, 150, 4, 519

    CrossRef

  24. 24
    David Ellenberg, Dimitri T. Azar, Joelle A. Hallak, Faisal Tobaigy, Kyu Yeon Han, Sandeep Jain, Zhongjun Zhou, Jin-Hong Chang, Novel aspects of corneal angiogenic and lymphangiogenic privilege, Progress in Retinal and Eye Research, 2010, 29, 3, 208

    CrossRef

  25. 25
    Alireza Foroutan, Beigzadeh Fariba, Bakhtiari Pejman, Joshaghani Mahmoud, Ghasemi Falavarjani Khalil, Ehteshami Afshar Arash, Pooria Foroutan, Perilimbal Bevacizumab Injection for Interface Neovascularization After Deep Anterior Lamellar Keratoplasty, Cornea, 2010, 29, 11, 1268

    CrossRef

  26. 26
    Ahmed A. Zaki, Samar F. Farid, Subconjunctival bevacizumab for corneal neovascularization, Acta Ophthalmologica, 2010, 88, 8
  27. 27
    Zohar Habot-Wilner, Irina S. Barequet, Yair Ivanir, Joseph Moisseiev, Mordechai Rosner, The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization, Acta Ophthalmologica, 2010, 88, 8
  28. 28
    Chih-Wei Wu, David Ellenberg, Jin-Hong Chang, Ocular Disease, 2010,

    CrossRef

  29. 29
    Wei-Li Chen, Yan-Ming Chen, Hsiao-Sang Chu, Ying-Han Lin, Tzu-Yun Tsai, Fung-Rong Hu, Bevacizumab for the Treatment of Corneal Neovascularization, Cornea, 2009, 28, Suppl 1, S26

    CrossRef

  30. 30
    A-P Bemelmans, Y Arsenijevic, F Majo, Efficient lentiviral gene transfer into corneal stroma cells using a femtosecond laser, Gene Therapy, 2009, 16, 7, 933

    CrossRef

  31. 31
    Joo Youn Oh, Mee Kum Kim, Won Ryang Wee, Subconjunctival and Intracorneal Bevacizumab Injection for Corneal Neovascularization in Lipid Keratopathy, Cornea, 2009, 28, 9, 1070

    CrossRef

  32. 32
    In-Cheon You, In-Seong Kang, Seung-Hyun Lee, Kyung-Chul Yoon, Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization, Acta Ophthalmologica, 2009, 87, 6
  33. 33
    Birgit Regenfuss, Felix Bock, Anand Parthasarathy, Claus Cursiefen, Corneal (Lymph)angiogenesis—From Bedside to Bench and Back: A Tribute to Judah Folkman, Lymphatic Research and Biology, 2008, 6, 3-4, 191

    CrossRef

  34. 34
    Jeanie Chui, Nick Di Girolamo, Denis Wakefield, Minas T. Coroneo, The Pathogenesis of Pterygium: Current Concepts and Their Therapeutic Implications, The Ocular Surface, 2008, 6, 1, 24

    CrossRef

  35. 35
    Patricia Chévez-Barrios, Are we getting closer to prevention and treatment of corneal neovascularization?, Clinical & Experimental Ophthalmology, 2007, 35, 8